The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase II preoperative window study of SAR439859 versus letrozole in post-menopausal women with newly diagnosed estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

Mario  Campone

Honoraria - Lilly; Novartis

Consulting or Advisory Role - Abbvie (Inst); Accord Healthcare (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); SERVIER (Inst)

Speakers' Bureau - Amgen; Novartis

Research Funding - Novartis (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer

Other Relationship - Roche

Christina Isabella  Herold

Employment - Sanofi

Qiuyan  Wang

Employment - Sanofi

Vasiliki  Pelekanou

Employment - Sanofi

Sylvaine  Cartot-Cotton

Employment - Sanofi

Bethany  Ling

Employment - Sanofi